Yahoo Web Search

  1. Aclaris Therapeutics Inc (NASDAQ: ACRS) shares were seeing some upward momentum Tuesday on the back of the announcement of a patent win. The U.S. Patent and Trademark Office has granted ...

  2. Biotech Braces for Busy Summer as 2019 M&A Volume Heats Up

    Bloomberg via Yahoo FinanceJul 03 14:41 PM

    “Do not sleep on the summer,” Jefferies trading specialist Jared Holz cautioned clients in a note. With regards to whether those deals will be mega-mergers or smaller bolt-ons, “anything is possible,” Holz said via phone.

  3. U.S. judge halts rule requiring drug prices in TV ads

    Reuters via Yahoo FinanceJul 08 22:25 PM

    District Judge Amit Mehta in Washington, D.C., sided with drugmakers Merck & Co Inc, Eli Lilly and Co and Amgen Inc by halting the U.S. Department of Health and Human Services ...

  4. Mirati Inks Deal with Novartis to Evaluate Tumor Candidate

    Zacks via Yahoo FinanceJul 10 21:53 PM

    Mirati Therapeutics, Inc. MRTX has inked a clinical collaboration agreement with Novartis AG (NVS) to evaluate the combination of the former's investigational KRAS G12C inhibitor, MRTX849 ...

  5. Why CorMedix Shares Are Rallying

    Benzinga via Yahoo FinanceJul 09 15:42 PM

    Shares of the micro-cap biotech CorMedix Inc. (NYSE: CRMD ) were advancing Tuesday following the announcement of positive FDA feedback on the company's lead investigational drug. What Happened The FDA's ...

  6. Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the Invesco Dynamic Biotechnology & Genome ETF (PBE) is a passively managed exchange traded fund ...

  7. Will Patent Woes Boost Pharma Stock Megamergers Further?

    Zacks via Yahoo FinanceJul 10 12:14 PM

    Generic competition can lower revenues of pharma stocks since blockbuster drugs are facing patent expirations. Moreover, President Trump's issuance of an executive order to slash drug prices ...

  8. The Franklin LibertyQ U.S. Equity ETF (FLQL) was launched on 04/26/2017, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Blend segment of the ...

  9. Why Amgen (AMGN) Could Beat Earnings Estimates Again

    Zacks via Yahoo FinanceJul 12 14:10 PM

    If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Amgen ...

  10. A judge in the United States District Court in the District of Columbia sentenced in support of Merck MRK, Eli Lilly LLY and Amgen AMGN determining that the Department of Health and Human ...

  1. Ads
    related to Amgen Inc